abstract |
A treatment using a combination of an antiviral agent and an EP4 receptor agonist for the treatment of human respiratory disease associated with viral infection is described. Viral infections include influenza A viruses, such as H1N1, H3N2, and H5N1, and variants thereof, and / or coronaviruses, such as viruses that cause severe acute respiratory syndrome “SARS”. |